PyInvesting

Market research

WST West Pharmaceutical Services Inc

NYSE USD Healthcare

Latest close

416.67 —

As of 29 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
27B
P/E ratio
49.16
Analyst target
412.875
Dividend yield
0.2%
Beta
1.12

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

West Pharmaceutical Services, Inc is currently in a long term uptrend where the price is trading 23.9% above its 200 day moving average.

From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.1.

West Pharmaceutical Services, Inc's total revenue rose by 23.1% to $579M since the same quarter in the previous year.

Its net income has increased by 53.7% to $98M since the same quarter in the previous year.

Finally, its free cash flow fell by 59.7% to $28M since the same quarter in the previous year.

Based on the above factors, West Pharmaceutical Services, Inc gets an overall score of 4/5.